Back to search
Limb-Girdle Muscular Dystrophy Type 2A
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Limb-Girdle Muscular Dystrophy Type 2A trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Limb-Girdle Muscular Dystrophy Type 2A trials you may qualify forThe purpose of this study is to evaluate the safety and tolerability of a single intravenous infusion of AB-1003 in adults diagnosed with limb girdle muscular d…
This is a 24-month, observational study of up to 1000 participants with Limb Girdle Muscular Dystrophy (LGMD), Myotonic Dystrophy Type 2 (DM2), and late onset P…
This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.
The goal of this Natural History Study for Charcot-Marie-Tooth is to acquire, record, and analyze patient-reported data and associated genetic reports, Electron…
Limb girdle muscular dystrophies were originally defined as a postnatal progressive muscle disease, which begins and primarily affects the pelvic and scapular m…
This study will follow participants who are screened and confirmed with a genetic diagnosis of Limb-girdle muscular dystrophy type 2E (LGMD2E/R4), Limb-girdle m…
This is an observational study, no drug (marketed or investigational) will be provided as part of the study, and the study procedures will have no impact on the…